Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa intraindividual trial of topical AVT-02 UE ointment in mild to moderate atopic dermatitis
2007-001969-15Phase 2Completed
- Sponsor
- Avontec
- Start
- Nov 2007
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing AVT-02 UE ointment marker area treatment with Placebo marker area treatment (2 arms). Primary endpoint: Change from baseline in modified EASI at week 4. Started Nov 2007; status: completed.
02
Drugs
AVT-02 UE ointment
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-001969-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001969-15.